The effect of noradrenergic attenuation by clonidine on inhibition in the stop signal task

Pharmacology Biochemistry and Behavior

Volumn 110, Issue , 2013, Pages 104-111

  Logemann, H N Alexander ^a   Böcker, Koen B E ^b   Deschamps, Peter K H ^c   Kemner, Chantal ^c   Kenemans, J Leon ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ALAN TURING INSTITUTE   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clonidine; Inhibition; N2; Noradrenaline; Norepinephrine; P3; SSRT

Indexed keywords

CLONIDINE; PLACEBO;

ADULT; ARTICLE; ATTENTION; BEHAVIOR; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; HUMAN; MALE; NORADRENERGIC SYSTEM; NORMAL HUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE;

CLONIDINE; INHIBITION; N2; NORADRENALINE; NOREPINEPHRINE; P3; SSRT;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; CLONIDINE; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; HUMANS; MALE; NOREPINEPHRINE; PLACEBOS; TASK PERFORMANCE AND ANALYSIS;

EID: 84879833726     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.06.007     Document Type: Article

References (46)

1. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 2003;6: 115-6. (Pubitemid 36182778)
2. Aston-Jones G, Cohen JD. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 2005;28: 403-50. (Pubitemid 41098911)
3. Band GP, van der Molen MW, Logan GD. Horse-race model simulations of the stopsignal procedure. Acta Psychol (Amst) 2003;112: 105-42. (Pubitemid 36881099)
4. Barkley RA. Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guildford; 1998.
5. Bekker EM, Kenemans JL, HoeksmaMR, Talsma D, Verbaten MN. The pure electrophysiology of stopping. Int J Psychophysiol 2005;55: 191-8. (Pubitemid 40093100)
6. Bellgrove MA, Hester R, Garavan H. The functional neuroanatomical correlates of response variability: evidence from a response inhibition task. Neuropsychologia 2004;42: 1910-6. (Pubitemid 39223300)
7. Berwid OG, Curko Kera EA, Marks DJ, Santra A, Bender HA, Halperin JM. Sustained attention and response inhibition in young children at risk for attention deficit/ hyperactivity disorder. J Child Psychol Psychiatry 2005;46: 1219-29. (Pubitemid 44202680)
8. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002;27: 699-711. (Pubitemid 35335888)
9. Chamberlain SR, Muller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 2006;311: 861-3. (Pubitemid 43228852)
10. Chamberlain SR, Del Campo N, Dowson J,Muller U, Clark L, Robbins TW, et al. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry 2007;62: 977-84. (Pubitemid 47562368)
11. Chamberlain SR, Hampshire A, Muller U, Rubia K, Del Campo N, Craig K, et al. Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry 2009;65: 550-5.
12. Corbetta M, Shulman GL. Control of goal-directed and stimulus-driven attention in the brain. Nat Rev 2002;3: 201-15. (Pubitemid 135706590)
13. Corbetta M, Patel G, Shulman GL. The reorienting system of the human brain: from environment to theory of mind. Neuron 2008;58: 306-24. (Pubitemid 351615192)
14. De Jong R, Coles MG, Logan GD, Gratton G. In search of the point of no return: the control of response processes. J Exp Psychol Hum Percept Perform 1990;16: 164-82.
15. De Jong R, Coles MG, Logan GD. Strategies andmechanisms in nonselective and selective inhibitory motor control. J Exp Psychol Hum Percept Perform 1995;21: 498-511.
16. Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry 2011;69:e145-57.
17. Eagle DM, Baunez C, Hutcheson DM, Lehmann O, Shah AP, Robbins TW. Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb Cortex 2008;18: 178-88. (Pubitemid 350233064)
18. Falkenstein M, Hohnsbein J, Hoormann J, Blanke L. Effects of crossmodal divided attention on late ERP components. II. Error processing in choice reaction tasks. Electroencephalogr Clin Neurophysiol 1991;78: 447-55.
19. Floden D, Stuss DT. Inhibitory control is slowed in patients with right superior medial frontal damage. J Cogn Neurosci 2006;18: 1843-9. (Pubitemid 44674283)
20. GehringWJ, Goss B, ColesMGH,Meyer DE, Donchin E. A neural systemfor error detection and compensation. Psychol Sci 1993;4: 385-90.
21. Gordon B, Allen EE, Trombley PQ. The role of norepinephrine in plasticity of visual cortex. Prog Neurobiol 1988;30: 171-91. (Pubitemid 18010541)
22. Graf H, Abler B, Freudenmann R, Beschoner P, Schaeffeler E, Spitzer M, et al. Neural correlates of error monitoring modulated by atomoxetine in healthy volunteers. Biol Psychiatry 2011;69: 890-7.
23. Gratton G, Coles MG, Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 1983;55: 468-84. (Pubitemid 13112654)
24. Johnson KA, Barry E, Bellgrove MA, Cox M, Kelly SP, Daibhis A, et al. Dissociation in response to methylphenidate on response variability in a group of medication naive children with ADHD. Neuropsychologia 2008;46: 1532-41.
25. Kenemans JL, Kahkonen S. Howhuman electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control. Neuropsychopharmacology 2011;36: 26-51.
26. Kenemans JL, Bekker EM, Lijffijt M, Overtoom CC, Jonkman LM, Verbaten MN. Attention deficit and impulsivity: selecting, shifting, and stopping. Int J Psychophysiol 2005;58: 59-70. (Pubitemid 41219520)
27. Kennedy SH, Gnam W, Ralevski E, Brown GM. Melatonin responses to clonidine and yohimbine challenges. J Psychiatry Neurosci 1995;20: 297-304.
28. Kramer AF, Wickens CD, Donchin E. Processing of stimulus properties: evidence for dual-task integrality. J Exp Psychol Hum Percept Perform 1985;11: 393-408.
29. Lansbergen MM, Bocker KB, Bekker EM, Kenemans JL. Neural correlates of stopping and self-reported impulsivity. Clin Neurophysiol 2007;118: 2089-103. (Pubitemid 47193193)
30. LiottiM, Pliszka SR, Perez III R, Luus B, Glahn D, Semrud-ClikemanM. Electrophysiological correlates of response inhibition in children and adolescents with ADHD: influence of gender, age, and previous treatment history. Psychophysiology 2007;44: 936-48. (Pubitemid 47609613)
31. Mangun GR, Hillyard SA. Modulations of sensory-evoked brain potentials indicate changes in perceptual processing during visual-spatial priming. J Exp Psychol Hum Percept Perform 1991;17: 1057-74.
32. Metting van Rijn AC, Peper A, Grimbergen CA. High-quality recording of bioelectric events. Part 1. Interference reduction, theory and practice. Med Biol Eng Comput 1990;28: 389-97. (Pubitemid 20299450)
33. Overtoom CC, Kenemans JL, Verbaten MN, Kemner C, van der Molen MW, van Engeland H, et al. Inhibition in children with attention-deficit/hyperactivity disorder: a psychophysiological study of the stop task. Biol Psychiatry 2002;51: 668-76. (Pubitemid 34310504)
34. Overtoom CC, Bekker EM, van der Molen MW, Verbaten MN, Kooij JJ, Buitelaar JK, et al. Methylphenidate restores link between stop-signal sensory impact and successful stopping in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2009;65: 614-9.
35. Pliszka SR. The neuropsychopharmacology of attention-deficit/ hyperactivity disorder. Biol Psychiatry 2005;57: 1385-90. (Pubitemid 40798559)
36. Pliszka SR, Liotti M, Woldorff MG. Inhibitory control in children with attentiondeficit/ hyperactivity disorder: event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. Biol Psychiatry 2000;48: 238-46. (Pubitemid 30618996)
37. Pliszka SR, Liotti M, Bailey BY, Perez III R, Glahn D, Semrud-Clikeman M. Electrophysiological effects of stimulant treatment on inhibitory control in children with attention-deficit/ hyperactivity disorder. J Child Adolesc Psychopharmacol 2007;17: 356-66. (Pubitemid 47067959)
38. Posner MI, Petersen SE. The attention system of the human brain. Annu Rev Neurosci 1990;13: 25-42. (Pubitemid 20100639)
39. Schmajuk M, Liotti M, Busse L, Woldorff MG. Electrophysiological activity underlying inhibitory control processes in normal adults. Neuropsychologia 2006;44: 384-95. (Pubitemid 41821900)
40. Svensson TH, Bunney BS, Aghajanian GK. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res 1975;92: 291-306.
41. Tannock R, Schachar RJ, Carr RP, Chajczyk D, Logan GD. Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol 1989;17: 473-91. (Pubitemid 19261803)
42. Wald FDM. De verkorte POMS. Master's thesis. Amsterdam: University of Amsterdam; 1984.
43. Wald, FDM, Mellenbergh, GJ. Instrumenteel onderzoek. Nederlands tijdschrift voor de psychologie 1990;45: 86-90.
44. Wester AE, Verster JC, Volkerts ER, Bocker KB, Kenemans JL. Effects of alcohol on attention orienting and dual-task performance during simulated driving: an event-related potential study. J Psychopharmacol 2010;24: 1333-48.
45. Woldorff MG. Distortion of ERP averages due to overlap from temporally adjacent ERPs: analysis and correction. Psychophysiology 1993;30: 98-119. (Pubitemid 23027781)
46. Zetterstrom T, Sharp T, Collin AK, Ungerstedt U. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur J Pharmacol 1988;148: 327-34.